Literature DB >> 2917791

Immunoglobulin M-dependent classical complement pathway activation in killing of Pentatrichomonas hominis.

M F Shaio1, J G Chen.   

Abstract

Complement pathway activity in the killing of Pentatrichomonas hominis was investigated in this study. At 10(5) organisms per ml, P. hominis was completely killed by the presence of 1% normal human serum. In contrast, no killing effect on P. hominis was observed when specific antibodies were absorbed or when the complement was destroyed. Moreover, Mg2+-ethylene glycol-bis-(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid-treated serum had no killing effect on P. hominis, while serum heated at 50 degrees C or treated with zymosan killed P. hominis as well as did normal human serum. Further study using gel filtration (Sephacryl S-300) and affinity chromatography (protein A) revealed that immunoglobulin M (IgM; 20 micrograms/ml) alone was responsible for the complement activation in the killing of P. hominis, but both IgA (24 micrograms/ml) and IgG (180 micrograms/ml) had no effect on complement-mediated lysis. On the other hand, IgG at 1,260 micrograms/ml completely inhibited complement-mediated killing by IgM, suggesting that a blocking factor is present in IgG. The results of this study indicate that a mechanism of IgM-dependent classical complement pathway activation contributes to the killing effect of normal human serum on P. hominis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2917791      PMCID: PMC313196          DOI: 10.1128/iai.57.3.902-906.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Interactions between Entamoeba histolytica and complement.

Authors:  G Huldt; P Davies; A C Allison; H U Schorlemmer
Journal:  Nature       Date:  1979-01-18       Impact factor: 49.962

2.  A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba.

Authors:  L S Diamond; D R Harlow; C C Cunnick
Journal:  Trans R Soc Trop Med Hyg       Date:  1978       Impact factor: 2.184

3.  Activation of the alternative pathway of complement by Entamoeba histolytica.

Authors:  L Ortiz-Ortiz; R Capin; N R Capin; B Sepúlveda; G Zamacona
Journal:  Clin Exp Immunol       Date:  1978-10       Impact factor: 4.330

4.  Activation of the alternate pathway of human complements by rabbit cells.

Authors:  T A Platts-Mills; K Ishizaka
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  A Trichomonas species in a mixed microbial meningitis.

Authors:  H Masur; E Hook; D Armstrong
Journal:  JAMA       Date:  1976-10-25       Impact factor: 56.272

7.  Role of blocking antibody in disseminated gonococcal infection.

Authors:  J A McCutchan; D Katzenstein; D Norquist; G Chikami; A Wunderlich; A I Braude
Journal:  J Immunol       Date:  1978-11       Impact factor: 5.422

8.  Identification of the activator system for antibody to Toxoplasma as the classical complement pathway.

Authors:  R D Schreiber; H A Feldman
Journal:  J Infect Dis       Date:  1980-03       Impact factor: 5.226

9.  C3 shunt activation in human serum chelated with EGTA.

Authors:  D P Fine; S R Marney; D G Colley; J S Sergent; R M Des Prez
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

10.  The properdin system and immunity. III. The zymosan assay of properdin.

Authors:  L PILLEMER; L BLUM; I H LEPOW; L WURZ; E W TODD
Journal:  J Exp Med       Date:  1956-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.